Leap Therapeutics Inc. (LPTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Leap Therapeutics Inc.

    NASDAQ: LPTX · Real-Time Price · USD
    0.61
    0.08 (15.99%)
    At close: Oct 02, 2025, 1:25 PM

    Leap Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a 1.5M
    Cost of Revenue
    		 5K 427K 415K n/a
    Gross Profit
    		 -5K -427K -415K 1.5M
    Operating Income
    		 -70.06M -87.04M -56.76M -41.43M
    Interest Income
    		 3.13M 4.03M 925K 9K
    Pretax Income
    		 -66.97M -81.41M -54.45M -40.61M
    Net Income
    		 -67.56M -81.41M -54.6M -40.59M
    Selling & General & Admin
    		 12.85M 13.38M 11.8M 10.77M
    Research & Development
    		 57.21M 73.23M 44.97M 32.16M
    Other Expenses
    		 n/a n/a -2.05M -1.23M
    Operating Expenses
    		 70.06M 86.61M 54.71M 41.7M
    Interest Expense
    		 n/a n/a 54K 41K
    Selling & Marketing Expenses
    		 n/a -427K n/a n/a
    Cost & Expenses
    		 70.06M 87.04M 54.71M 41.7M
    Income Tax Expense
    		 585K n/a 147K -24K
    Shares Outstanding (Basic)
    		 37.55M 20.45M 11.32M 8.58M
    Shares Outstanding (Diluted)
    		 37.55M 20.45M 11.32M 8.58M
    EPS (Basic)
    		 -1.81 -3.98 -4.82 -4.73
    EPS (Diluted)
    		 -1.81 -3.98 -4.82 -4.73
    EBITDA
    		 -66.97M -80.99M -53.98M -40.01M
    EBIT
    		 -66.97M -81.41M -54.4M -40.57M
    Depreciation & Amortization
    		 5K 427K 415K 556K

    Add to Watchlist